ロード中...
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure
BACKGROUND: A vaccine trial with a conventional challenge design can be very fast once it starts, but it requires a long prior process, in part to grow and standardize challenge virus in the laboratory. This detracts somewhat from its overall promise for accelerated efficacy testing of severe acute...
保存先:
| 出版年: | Clin Microbiol Infect |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7787506/ https://ncbi.nlm.nih.gov/pubmed/33421580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2020.12.032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|